Institution
Sun Yat-sen University
Also known as: 中山大学
- 13running trials
- 3closed trials
- 2researchers
- 251,558publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Recruiting
Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
Not yet recruiting
Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC
Not yet recruiting
Recruiting
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
Active, not recruiting
Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
Recruiting
Recruiting
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- High blood pressure2 recruiting
- Lung cancer2 recruiting
- Alzheimer disease1 recruiting
- Childhood cancers1 recruiting
- Congenital heart disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Mild cognitive impairment1 recruiting
- Vascular dementia1 recruiting
Closed trials
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Sun Yat-sen University
Guangzhou, Guangdong 510000
15 trials
Department of Medical Statistics & Epidemiology, School of Public Health, Sun Yat-sen University
Guangzhou, 510080
1 trial
NCT03569735Nanshan Elderly Cohort Study
Contact: Yuming Chen
Conditions
Diseases this institution publishes on or runs trials for.
- Liver and biliary tract cancer357 works · 1 trial
- Colorectal cancer303 works · 3 trials
- Lung cancer238 works · 3 trials
- Stroke235 works · 1 trial
- Obesity168 works · 2 trials
- Gastric and oesophageal cancer146 works · 2 trials
- Type 2 diabetes116 works · 1 trial
- Heart failure106 works · 0 trials
- Alzheimer disease103 works · 1 trial
- Prostate cancer98 works · 0 trials
- Chronic kidney disease96 works · 1 trial
- Crohn's disease89 works · 0 trials
- Bladder cancer82 works · 0 trials
- Parkinson disease70 works · 0 trials
- Glaucoma70 works · 0 trials
- Triple-negative breast cancer65 works · 0 trials
- Melanoma64 works · 1 trial
- Ovarian cancer63 works · 0 trials
- Fatty liver disease (MASLD/MASH)62 works · 0 trials
- Osteoarthritis59 works · 0 trials
- Ulcerative colitis59 works · 0 trials
- Kidney cancer56 works · 0 trials
- Pancreatic cancer53 works · 0 trials
- Asthma50 works · 0 trials
- Cervical cancer49 works · 0 trials
- Osteoporosis47 works · 0 trials
- Sarcoma47 works · 0 trials
- Rheumatoid arthritis47 works · 0 trials
- Tuberculosis46 works · 0 trials
- Glioblastoma43 works · 0 trials
Institution data: ROR 0064kty71 (CC0-1.0)Updated 15 Nov 2026